VRN110755 Phase 1/2 Trial Target Raised to 355 Subjects, Australia Amendment Filed
Following an Australian protocol update, the VRN110755 Phase 1/2 trial target was changed from around 255 to around 355 subjects in an amendment application.
310210 · KOSDAQ · Based on DART filings
1 total · 20 per page
Following an Australian protocol update, the VRN110755 Phase 1/2 trial target was changed from around 255 to around 355 subjects in an amendment application.
Get app alerts for new disclosures from Voronoi, Inc..